 |
 |
|
|
|
| vandetanib |
 |
| C22H24BrFN4O2 |
 |
| 443913-73-3 |
 |
| treatment of advanced multiple myeloma |
 |
vandetanib
Other name:
4-(4-bromo-2-fluoroanilino)-6-methoxy-7-[(1-methyl-piperidin -4-yl) methoxy] quinazoline
Formula C22H24BrFN4O2
Molecular Weight 475.35
CAS Registry Number 443913-73-3
Density of 1.406
Uses: treatment of advanced multiple myeloma |
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
